02.12.2020   13:00

IZN Concepts Talk

 

Stem cells and cancer in the central nervous system

Dr. Haikun Liu

German Cancer Research Center

DKFZ-ZMBH Alliance

 

Location: ZOOM

The link will be shared on the IZN Mailing Lists

 

09.12.2020   13:00

IZN Seminar

 

Cracking the NMDAR/TRPM4 coupling: the discovery of unconventional neuroprotectants against excitotoxicity

Dr. Jing Yan (AG Bading)

 

Coordinated prefrontal state transition leads extinction of reward-seeking behaviors

Dr. Georg Köhr (AG Köhr)

 

Location: ZOOM

The link will be shared on the IZN Mailing Lists

 

16.12.2020   13:00

IZN Concepts Talk

 

Apical and Basal neural stem cells in the SVZ: contribution to neurogenesis and niche homeostasis

Dr. Francesca Ciccolini

Neurobiology

University Heidelberg

 

Location: ZOOM

The link will be shared on the IZN Mailing Lists

 

Welcome to the IZN Home Page

Selected cells
 
Kuner T Fig1
 
Pauen Fig1
 
Poggi Figure2
 
Rappold Fig1
 
Holstein Fig1

News...

New Class of Highly Effective Inhibitors Protects against Neurodegeneration

Heidelberg neurobiologists decode central mechanism of degenerative processes in the brains of mouse models and develop new principle for therapeutic agents

Neurobiologists at Heidelberg University have discovered how a special receptor at neuronal junctions that normally activates a protective genetic programme can lead to nerve cell death when located outside synapses. Their fundamental findings on neurodegenerative processes simultaneously led the researchers at the Interdisciplinary Center for Neurosciences (IZN) to a completely new principle for therapeutic agents. In their experiments on mouse models, they discovered a new class of highly effective inhibitors for protecting nerve cells. As Prof. Dr Hilmar Bading points out, this novel class of drugs opens up – for the first time – perspectives to combat currently untreatable diseases of the nervous system. The results of this research were published in “Science”.

The research by Prof. Bading and his team is focused on the so-called NMDA receptor. This receptor is an ion channel protein that is activated by a biochemical messenger: the neurotransmitter glutamate. It allows calcium to flow into the cell. The calcium signal sets in motion plasticity processes in the synapse but also propagates into the cell nucleus, where it activates a protective genetic programme. Glutamate-activated NMDA receptors located in the junctions of the nerve cells have a key function in the brain, contributing to learning and memory processes as well as neuroprotection. But the same receptors are also found outside of synapses. These extra-synaptic NMDA receptors pose a threat because their activation can lead to cell death. Normally, however, efficient cellular uptake systems for glutamate make sure that these receptors are not activated and nerve cells remain undamaged. More...


Gene defect influences tumor development in childhood brain tumors

Medulloblastoma are the most common malignant brain tumors affecting children. The greatest danger is that the cancer cells can quickly spread to the surrounding tissues. Two genetic defects play a key role in the onset of these tumors, as scientists at the Hopp Children's Cancer Center Heidelberg (KiTZ), the German Cancer Research Center (DKFZ) and the National Institute of Neuroscience in Tokyo have discovered. The aim is for the findings to help scientists develop personalized treatment strategies for young patients.

At the Hopp Children's Cancer Center Heidelberg (KiTZ), scientists are conducting intensive research into the onset of medulloblastoma in order to develop new therapy options. "The onset of malignant medulloblastoma cells has genetic causes and follows several stages," explains Lena Kutscher, a Junior Group Leader at the KiTZ and the DKFZ. "First, genetic mutations cause excessive proliferation of certain precursor nerve cells, and growths develop. If more mutations occur, they can turn into malignant tumor cells that spread into the surrounding tissue."

Together with colleagues from the National Institute of Neuroscience in Tokyo and from St. Jude Children's Hospital in the USA, the research team came across two key genetic drivers for the onset of medulloblastoma in the Sonic Hedgehog medulloblastoma subgroup (SHH). The BCOR gene is regarded as a tumor suppressor gene, and its protein product normally suppresses the uncontrolled division of cells with genetic defects, thereby preventing the onset of tumors. Earlier studies have shown that in eight percent of young SHH patients, BCOR is mutated or has been partially deleted from the genome. Boys are particularly affected by this mutation. More...


Chs Logo2016 Cmyk Pfade English2

Oliveira AnaThe Chica and Heinz Schaller Foundation is proud to announce a CHS Research Awards winner 2020: Dr. Ana Oliveira


Heidelberg researchers investigate new approaches to treating neurodegenerative diseases

Bading2MauceripicProtecting nerve cells from losing their characteristic extensions, the dendrites, can reduce brain damage after a stroke. Neurobiologists from Heidelberg University have demonstrated this by means of research on a mouse model. The team, led by Prof.Dr. Hilmar Bading in cooperation with Junior Professor Dr. Daniela Mauceri, is investigating the protection of neuronal architecture to develop new approaches to treating neurodegenerative diseases. The current research findings were published in the journal “Proceedings of the National Academy of Sciences”.

Brain nerve cells possess many arborised dendrites, which can make connections with other neurons. The highly complex, ramified structure of neurons is an important precondition for their ability to connect with other nerve cells, in order to enable the brain to function normally. In earlier studies, the Heidelberg researchers identified the signal molecule VEGFD – Vascular Endothelial Growth Factor D – as a central regulator for maintaining and restoring neuronal structures. “Our current research results demonstrate that a stroke as a consequence of an interruption of the blood supply to the brain leads to a reduction of VEGFD levels. That causes the nerve cells to lose part of their dendrites. They shrink and this leads to impairments of the cognitive and motor abilities,” explains Prof. Bading.

Based on these findings, the researchers at the Interdisciplinary Centre for Neurosciences explored the question of whether the reduction of neuronal structures after a stroke can be prevented by restoring the VEGFD levels. More...


Seitenanfang

Open positions at the IZN

  • Dr. Hai-Kun Liu's lab is seeking a highly motivated postdoctoral candidate to work on stem cells and cancer in the central nervous system. The lab is currently focusing on finding novel therapeutic target in human glioblastoma, applying a wide range of cutting-edge techniques (mouse models, single-cell technology, single molecule FISH, human organoid etc). The project will involve using established human glioma organoid systems, studying cellular heterogeneity and treatment response with the aim to find novel targeting strategy and translate that into clinical practice. Adobe
    Posted 11.2020

  • The lab of Dr. Moritz Mall at the DKFZ is looking for a postdoc, preferably with neuroscience or extensive tissue culture experience, for  stem cell-based neurological disease modeling efforts using cutting-edge technologies. The tasks include genetic engineering, stem cell culture and differentiation as well as functional analysis of induced human neurons using a wide range of innovative technologies and research infrastructure. Adobe
    Posted 10.2020

  • A postdoc/scientific assistant position is offered in the Research Group 'General Neurophysiology' (Prof. Dr. Oliver Kann) at the Institute of Physiology and Pathophysiology, University of Heidelberg. The group focuses on (i) mitochondria and energy metabolism during neuronal activity, and (ii) the impact of activated microglia (brain macrophages) on neuronal activity and neurodegeneration. Adobe
    Posted 07.2020

  • Two positions for postdoctoral or doctoral researchers in the department of Functional Neuroanatomy (Prof T. Kuner) are available in a consortium which aims to visualize multi-protein networks in nervous tissue with near-molecular optical resolution. Adobe
    Posted 02.2020

  • The research group of Dr. Kevin Allen is seeking a highly motivated PhD student to work on the neuronal basis of spatial behavior. The student will use a wide array of techniques to study system neuroscience, including in vivo tetrode and silicon probe recordings in mice, optogenetics, behavioral testing, analysis of large databases and histological analysis. Adobe
    Posted 11.2019


Seitenanfang

Contact

 

Managing Director:
Prof. Dr. Hilmar Bading
IZN-Neurobiology, University of Heidelberg
Im Neuenheimer Feld 366, 1.OG
D-69120 Heidelberg, Germany

 

Phone:  +49 - 6221 - 54 16500
Fax:  +49 - 6221 - 54 16524
email:  Bading@nbio.uni-heidelberg.de

 

 

 

Coordinator IZN and IZN PhD Programme:
Dr. Otto Bräunling
IZN-Neurobiology, University of Heidelberg
Im Neuenheimer Feld 366, 1.OG
D-69120 Heidelberg, Germany

 

Phone:  +49 - 6221 - 54 16502
Fax:  +49 - 6221 - 54 16524
email:  Braeunling@nbio.uni-heidelberg.de

 

 

 

Administration & Information:
Herr Ferhat Dikmen
IZN-Neurobiology, University of Heidelberg
Im Neuenheimer Feld 366, 1.OG
D-69120 Heidelberg, Germany

 

Phone:  +49 - 6221 - 54 16501
Fax:  +49 - 6221 - 54 16524
email:  Sekretariat@nbio.uni-heidelberg.de

 

Webmaster contact: WebmasterIZN@uni-heidelberg.de
Latest Revision: 2020-11-26
zum Seitenanfang/up